Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lev M Berstein

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|September 5, 2015
Cancer endocrinology: noticeable developments in the last decadeLev M Berstein
Future Oncology (London, England)|November 15, 2019
Dissimilar associations of same metabolic parameters with main chronic noncommunicable diseases (cancer vs some other NCDs)Lev M Berstein
Cancer Letters|May 26, 2005
Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancerLev M Berstein
Future Oncology (London, England)|February 5, 2008
Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesisLev M Berstein
Oncotarget|January 11, 2019
New developments of metformin in the clinical cancer areaLev M Berstein
Future Oncology (London, England)|April 21, 2009
Metformin, insulin, breast cancer and moreLev M Berstein
Advances in Experimental Medicine and Biology|July 22, 2008
Role of endocrine-genotoxic switchings in cancer and other human diseases: basic triadLev M Berstein
Women'S Health (London, England)|July 6, 2013
High baby birth weight and risk of hormone-associated cancer in mothers: the cancer-cardiovascular disease dichotomy and its possible causesLev M Berstein
Advances in Experimental Medicine and Biology|July 22, 2008
Innovative endocrinology of cancer. PrefaceLev M Berstein, Richard J Santen
Future Science OA|December 30, 2016
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseasesAlexander O Shpakov, Kira V Derkach, Lev M Berstein
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|September 5, 2015
Cancer endocrinology: noticeable developments in the last decadeLev M Berstein
Future Oncology (London, England)|November 15, 2019
Dissimilar associations of same metabolic parameters with main chronic noncommunicable diseases (cancer vs some other NCDs)Lev M Berstein
Cancer Letters|May 26, 2005
Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancerLev M Berstein
Future Oncology (London, England)|February 5, 2008
Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesisLev M Berstein
Oncotarget|January 11, 2019
New developments of metformin in the clinical cancer areaLev M Berstein
Future Oncology (London, England)|April 21, 2009
Metformin, insulin, breast cancer and moreLev M Berstein
Advances in Experimental Medicine and Biology|July 22, 2008
Role of endocrine-genotoxic switchings in cancer and other human diseases: basic triadLev M Berstein
Women'S Health (London, England)|July 6, 2013
High baby birth weight and risk of hormone-associated cancer in mothers: the cancer-cardiovascular disease dichotomy and its possible causesLev M Berstein
Advances in Experimental Medicine and Biology|July 22, 2008
Innovative endocrinology of cancer. PrefaceLev M Berstein, Richard J Santen
Future Science OA|December 30, 2016
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseasesAlexander O Shpakov, Kira V Derkach, Lev M Berstein
Pageof 5